webinar register page

Webinar banner
Webinar on ICER's Assessment on Barriers to Fair Access
On Friday, Dec 3rd, we will be hosting a webinar with ICER’s Executive Vice President and Chief Operating Officer Sarah Emond, MPP on the key conclusions of our “Fair Access” initiative. The goal of this project is to spark further dialogue and action in the best interest of patients by providing an independent analysis of whether or not major insurers are providing appropriate access for drugs that have been responsibly priced.

Dec 3, 2021 12:00 PM in Eastern Time (US and Canada)

* Required information


Cat Davis Ahmed, MBA
Vice President for Policy and Outreach @FH Foundation
Cat Davis Ahmed is Vice President for Policy and Outreach for the FH Foundation, where she works with individuals living with, or at risk for, early cardiovascular disease due to inherited lipid disorders (Familial Hypercholesterolemia and elevated Lipoprotein(a)) and the medical professionals who treat them. She is a co-author of publications in the Journal of the American College of Cardiology, Circulation, and Atherosclerosis. Cat is a member of the American Heart Association’s Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young and Co-Investigator on the NIH-funded “Identification Methods, Patient Activation, and Cascade Testing for FH” (IMPACT-FH) study to improve detection of, and family screening for, FH. She speaks at national medical conferences, including the American Heart Association Scientific Sessions, ISPOR, and the Global Cardiovascular Clinical Trialists Forum.
Douglas White, MD, Ph.D.
Douglas White, MD, Ph.D. earned his MD and Ph.D. degrees from the University of Iowa, followed by residency training in Internal Medicine at Parkland Hospital (UT-Southwestern) and fellowship training in rheumatology at Barnes-Jewish Hospital (Washington University invSt. Louis). His Ph.D. focused on effector functions of CD8 T cells and post-doctoral training on herpesvirus interactions with the host immune system. In 2009 he became the Chair of Rheumatology and the head of the Rheumatology Research lab at Gundersen Health System in Wisconsin. He is a Clinical Adjunct Assistant Professor in the Department of Medicine at the University of Wisconsin School of Medicine and Public Health and President-elect at the American College of Rheumatology where he has served in a number of roles since 2011. He also serves on the board of directors of the Local Lupus Alliance.
Rebecca Kirch, JD
Executive Vice President of Policy and Programs @National Patient Advocate Foundation
Rebecca Kirch is EVP of Policy and Programs for the National Patient Advocate Foundation (NPAF) based in Washington, DC. In this role, she provides strategic focus and leadership in bringing patient and caregiver voices and values to the forefront of health reform efforts through influential advocacy and grassroots mobilization. A frequently invited speaker on patient and family engagement about person-centered care practices, Rebecca has authored numerous articles and book chapters, including publications in the New England Journal of Medicine, Archives of Internal Medicine, Health Equity, JAMA Oncology, Health Affairs, Circulation and other professional journals. Among advisory committees and advocacy coalitions, Rebecca is currently an active participant of the National Academy of Science, Engineering and Medicine’s (NASEM) Quality Care for People with Serious Illness Roundtable, policy advisor for the Patient Advocate Foundation’s Patient Insight Institute, and other groups.